Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
PFE holding history
Pfizer Inc in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −11,929−100.0% | Sold out | Holders |
| Q4 2023 | 11,929 | $343.4K | <0.1% | −10,277−46.3% | Reduced | Holders |
| Q3 2023 | 22,206 | $736.4K | 0.1% | −1,920−8.0% | Reduced | Holders |
| Q2 2023 | 24,126 | $884.9K | 0.1% | −1,404−5.5% | Reduced | Holders |
| Q1 2023 | 25,530 | $1.04M | 0.1% | +59+0.2% | Added | Holders |
| Q4 2022 | 25,471 | $1.31M | 0.1% | +300+1.2% | Added | Holders |
| Q3 2022 | 25,171 | $1.10M | 0.1% | +364+1.5% | Added | Holders |
| Q2 2022 | 24,807 | $1.30M | 0.1% | −1,021−4.0% | Reduced | Holders |
| Q1 2022 | 25,828 | $1.34M | 0.1% | −1,126−4.2% | Reduced | Holders |
| Q4 2021 | 26,954 | $1.59M | 0.1% | −282−1.0% | Reduced | Holders |
| Q3 2021 | 27,236 | $1.17M | 0.1% | −990−3.5% | Reduced | Holders |
| Q2 2021 | 28,226 | $1.11M | 0.1% | +664+2.4% | Added | Holders |
| Q1 2021 | 27,562 | $999.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.